Edvard Abel

Edvard Abel is affiliated with the Department of Oncology at the University of Gothenburg, where he conducts research focused on radiation oncology and quality-of-life outcomes in cancer patients. He defended his doctoral thesis in oncology in 2022, titled *"Effects on quality of life of new radiotherapy techniques in treatment of head and neck cancer"*. His work emphasizes improving patient outcomes through advanced radiotherapy techniques, precision medicine, and clinical trial design.

Dr. Abel's research interests include genomics-guided therapy, neurological effects of radiotherapy, and optimizing patient care through interdisciplinary collaboration. His publications span topics such as biomarker-driven clinical trials (MEGALiT trial), international precision medicine initiatives (PCM4EU/PRIME-ROSE), and longitudinal studies on long-term quality of life in head and neck cancer survivors.

His research has been published in journals like *Acta Oncologica*, *Advances in Radiation Oncology*, and *Journal of Clinical Oncology*. While no specific awards are listed, his contributions highlight advancements in oncology treatment protocols and patient-centered care.

Dr. Abel collaborates with Sahlgrenska University Hospital and contributes to clinical research teams focused on oncology innovation. His work underscores a commitment to bridging translational research with clinical practice to enhance cancer treatment efficacy and patient well-being.